195 related articles for article (PubMed ID: 10365744)
1. Longitudinal analysis of factor VIII inhibitors in a previously untreated mild haemophilia A patient with an Arg593-->Cys substitution.
van den Brink EN; Timmermans SM; Turenhout EA; Bank CM; Fijnvandraat K; Voorberg J; Peters M
Thromb Haemost; 1999 May; 81(5):723-6. PubMed ID: 10365744
[TBL] [Abstract][Full Text] [Related]
2. HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation.
Bril WS; MacLean PE; Kaijen PH; van den Brink EN; Lardy NM; Fijnvandraat K; Peters M; Voorberg J
Haemophilia; 2004 Sep; 10(5):509-14. PubMed ID: 15357778
[TBL] [Abstract][Full Text] [Related]
3. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
[TBL] [Abstract][Full Text] [Related]
4. Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitors.
Sawamoto Y; Prescott R; Zhong D; Saenko EL; Mauser-Bunschoten E; Peerlinck K; van den Berg M; Scandella D
Thromb Haemost; 1998 Jan; 79(1):62-8. PubMed ID: 9459325
[TBL] [Abstract][Full Text] [Related]
5. The missense mutation Arg593 --> Cys is related to antibody formation in a patient with mild hemophilia A.
Fijnvandraat K; Turenhout EA; van den Brink EN; ten Cate JW; van Mourik JA; Peters M; Voorberg J
Blood; 1997 Jun; 89(12):4371-7. PubMed ID: 9192760
[TBL] [Abstract][Full Text] [Related]
6. Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population.
Boekhorst J; Verbruggen B; Lavergne JM; Costa JM; Schoormans SC; Brons PP; van Kraaij MG; Nováková IR; van Heerde WL
Br J Haematol; 2005 Oct; 131(1):109-17. PubMed ID: 16173970
[TBL] [Abstract][Full Text] [Related]
7. Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes.
Gilles JG; Lavend'homme R; Peerlinck K; Jacquemin MG; Hoylaerts M; Jorieux S; Mazurier C; Vermylen J; Saint-Remy JM
Thromb Haemost; 1999 Jul; 82(1):40-5. PubMed ID: 10456452
[TBL] [Abstract][Full Text] [Related]
8. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
Greninger DA; Saint-Remy JM; Jacquemin M; Benhida A; DiMichele DM
Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
[TBL] [Abstract][Full Text] [Related]
9. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
[TBL] [Abstract][Full Text] [Related]
10. Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development.
d'Oiron R; Pipe SW; Jacquemin M
Haemophilia; 2008 Jul; 14 Suppl 3():138-46. PubMed ID: 18510534
[TBL] [Abstract][Full Text] [Related]
11. Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia A patient with an Arg593 to Cys mutation.
Thompson AR; Murphy ME; Liu M; Saenko EL; Healey JF; Lollar P; Scandella D
Blood; 1997 Sep; 90(5):1902-10. PubMed ID: 9292523
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain.
Laub R; Di Giambattista M; Fondu P; Brackmann HH; Lenk H; Saenko EL; Felch M; Scandella D
Thromb Haemost; 1999 Jan; 81(1):39-44. PubMed ID: 9974372
[TBL] [Abstract][Full Text] [Related]
13. Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia A patients with factor VIII inhibitor.
Sugihara T; Takahashi I; Kojima T; Okamoto Y; Yamamoto K; Kamiya T; Matsushita T; Saito H
Nagoya J Med Sci; 2000 May; 63(1-2):25-39. PubMed ID: 10911718
[TBL] [Abstract][Full Text] [Related]
14. Analysis of factor VIII inhibitors in a haemophilia A patient with an Arg593-->Cys mutation using phage display.
Bril WS; Turenhout EA; Kaijen PH; van den Brink EN; Koopman MM; Peters M; Voorberg J
Br J Haematol; 2002 Nov; 119(2):393-6. PubMed ID: 12406075
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopes.
Suzuki H; Shima M; Arai M; Kagawa K; Fukutake K; Kamisue S; Nakai H; Morichika S; Tanaka I; Inoue M; Gale K; Tuddenham EG; Yoshioka A
Thromb Haemost; 1997 May; 77(5):862-7. PubMed ID: 9184393
[TBL] [Abstract][Full Text] [Related]
16. Properties of anti-factor VIII inhibitor antibodies in hemophilia A patients.
Scandella DH
Semin Thromb Hemost; 2000; 26(2):137-42. PubMed ID: 10919405
[TBL] [Abstract][Full Text] [Related]
17. Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group.
Goodeve AC; Williams I; Bray GL; Peake IR
Thromb Haemost; 2000 Jun; 83(6):844-8. PubMed ID: 10896236
[TBL] [Abstract][Full Text] [Related]
18. Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate.
Peerlinck K; Arnout J; Di Giambattista M; Gilles JG; Laub R; Jacquemin M; Saint-Remy JM; Vermylen J
Thromb Haemost; 1997 Jan; 77(1):80-6. PubMed ID: 9031454
[TBL] [Abstract][Full Text] [Related]
19. Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.
Boekhorst J; Lari GR; D'Oiron R; Costa JM; Nováková IR; Ala FA; Lavergne JM; VAN Heerde WL
Haemophilia; 2008 Jul; 14(4):729-35. PubMed ID: 18503540
[TBL] [Abstract][Full Text] [Related]
20. Factor VIII inhibitor in a patient with mild haemophilia A and an Asn618-->Ser mutation responsive to immune tolerance induction and cyclophosphamide.
Vlot AJ; Wittebol S; Strengers PF; Turenhout EA; Voorberg J; van den Berg HM; Mauser-Bunschoten EP
Br J Haematol; 2002 Apr; 117(1):136-40. PubMed ID: 11918545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
